mcr-1通过十二指肠镜传播的首例美国报告
研究调查了美国波士顿一家三级学术医疗中心内两例高度相关的mcr-1阳性肺炎克雷伯菌感染,十二指肠镜是唯一流行病学联系。对20名医护人员和2名家庭接触者筛查均为阴性,十二指肠镜培养出肺炎克雷伯菌和大肠埃希菌但均未携带mcr-1,镜体密封远端帽下发现生物材料侵入,器械被召回修复。结论认为mcr-1可能经十二指肠镜传播,尽管未发现再处理或感染控制缺陷。
要点
- mcr-1阳性肺炎克雷伯菌可能经十二指肠镜在患者间传播,需警惕器械相关传播。
- 十二指肠镜设计缺陷导致多层耐药菌传播持续存在,尽管已采取改进措施。
- 临床实验室可靠检测黏菌素耐药性困难,尤其美国尚无FDA批准的检测方法。
核心结论
- 在美国急性照护医院中识别出mcr-1传播,可能经十二指肠镜发生,尽管未发现再处理或感染控制操作中的可识别失误。
研究设计与样本
- 现场调查,包括针对高危人群的筛查、十二指肠镜评估和分离菌株的全基因组测序。
- 研究地点包括马萨诸塞州波士顿一家三级学术医疗中心,并扩展至新英格兰社区地点。
主要发现
- 两名患者的临床培养分离出高度相关的mcr-1阳性肺炎克雷伯菌,十二指肠镜是唯一确定的流行病学联系。
- 对20名医护人员接触者和2名家庭接触者进行mcr-1筛查,结果均为阴性。
- 从十二指肠镜回收出肺炎克雷伯菌和大肠埃希菌,但二者均不携带mcr-1。
- 十二指肠镜评估发现密封远端帽下有生物材料侵入,器械被召回以修复该缺陷。
关键数值与推荐
- 两例患者分离的mcr-1阳性肺炎克雷伯菌高度相关。
- 20名医护人员接触者和2名家庭接触者的mcr-1筛查均为阴性。
- 十二指肠镜回收的肺炎克雷伯菌和大肠埃希菌均不携带mcr-1。
临床怎么用
- 临床应关注十二指肠镜相关传播多层耐药菌的风险,即使再处理操作未见明显失误。
- 需改进临床实验室对黏菌素敏感性的检测能力,尤其在美国缺乏FDA批准检测的情况下。
局限性
- 筛查仅覆盖20名医护人员接触者和2名家庭接触者,样本量有限。
- 十二指肠镜回收菌株未携带mcr-1,未直接从器械分离到mcr-1阳性菌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinicians increasingly utilize polymyxins for treatment of serious infections caused by multidrug-resistant gram-negative bacteria. Emergence of plasmid-mediated, mobile colistin resistance genes creates potential for rapid spread of polymyxin resistance. We investigated the possible transmission of Klebsiella pneumoniae carrying mcr-1 via duodenoscope and report the first documented healthcare transmission of mcr-1-harboring bacteria in the United States. METHODS: A field investigation, including screening targeted high-risk groups, evaluation of the duodenoscope, and genome sequencing of isolated organisms, was conducted. The study site included a tertiary care academic health center in Boston, Massachusetts, and extended to community locations in New England. RESULTS: Two patients had highly related mcr-1-positive K. pneumoniae isolated from clinical cultures; a duodenoscope was the only identified epidemiological link. Screening tests for mcr-1 in 20 healthcare contacts and 2 household contacts were negative. Klebsiella pneumoniae and Escherichia coli were recovered from the duodenoscope; neither carried mcr-1. Evaluation of the duodenoscope identified intrusion of biomaterial under the sealed distal cap; devices were recalled to repair this defect. CONCLUSIONS: We identified transmission of mcr-1 in a United States acute care hospital that likely occurred via duodenoscope despite no identifiable breaches in reprocessing or infection control practices. Duodenoscope design flaws leading to transmission of multidrug-resistant organsisms persist despite recent initiatives to improve device safety. Reliable detection of colistin resistance is currently challenging for clinical laboratories, particularly given the absence of a US Food and Drug Administration-cleared test; improved clinical laboratory capacity for colistin susceptibility testing is needed to prevent the spread of mcr-carrying bacteria in healthcare settings.
引用
- Shenoy ES, Pierce VM, Walters MS, et al. Transmission of Mobile Colistin Resistance (mcr-1) by Duodenoscope. Clin Infect Dis. 2019. PMID: 30204838. doi:10.1093/cid/ciy683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。